Genetics and Multi-Omics Specimen
Steven Arnold, MD
Professor of Neurology
Harvard Medical School
- Email: searnold@mgh.harvard.edu
Steven Arnold is the Translational Neurology Head and Managing Director of the Interdisciplinary Brain Center, a collaboration of the Departments of Neurology, Psychiatry and the Martinos Center for Neuroimaging. Its mission is to facilitate the discovery, development, and implementation of promising therapeutics and associated diagnostics for individuals with complex brain disorders that affect cognition, behavior and emotion. Neurodegenerative diseases are major disease interests of the Interdisciplinary Brain Center.
Arnold has conducted longstanding research on neurodegenerative disease pathology, molecular biomarkers and therapeutics for cognitive decline and psychiatric syndromes in late life and has led broad clinical and translational research programs. He has authored over 300 scientific articles, reviews and chapters. Current scientific interests include biomarkers in brain aging and dementias, metabolic factors driving dementia, and protective factors that account for cognitive resilience, all towards accelerating therapeutics discovery and development in early phase and proof-of-concept clinical trials for neurocognitive disorders.
Carlos Cruchaga, PhD
Professor of Psychiatry
Washington University School of Medicine in St. Louis
- Email: cruchagac@wustl.edu
Carlos Cruchaga is the Barbara Burton & Reuben Morriss III Professor of Psychiatry with joint appointments at Genetics, and Neurology at Washington University School of Medicine. Cruchaga is a human genomicist with expertise in multiomics, informatics, and neurodegeneration. He completed his PhD in biochemistry and molecular biology in 2005 at the University of Navarra in Spain. During his first postdoc with Dr. Pastor he conducted statistical human genetics studies focused on Alzheimers disease (AD) and Parkinson’s disease (PD). He then moved to Dr. Goate’s Lab to complete his training in quantitative human genomics. Dr. Cruchaga established his laboratory at Washington University in 2011 to study the genetic architecture of neurodegenerative diseases. His interests are focused on using human genomic and other -omic data (proteomics, metabolomics, and lipidomics) to identify and understand the biological processes that lead to AD, PD, frontotemporal dementia, and other neurodegenerative processes. He is the founding director of the NeuroGenomics and Informatics Center at Washington University. The Cruchaga lab can be found at cruchagalab.wustl.edu.